Vera Therapeutics' Lead Kidney Drug Poised For 2026 Launch In Multi-Billion-Dollar Market

benzinga.com/analyst-stock-ratings/initiation/25/10/48260116/vera-therapeutics-lead-kidney-drug-poised-for-2026-launch-in-multi-billion-dolla

BofA Securities initiated coverage on Vera Therapeutics, Inc. (NASDAQ:VERA), ahead of a key catalyst in 2026 for its lead drug, atacicept, for kidney disease.
• VERA is facing resistance from sellers. Track the action here.
Analyst Dina Ramadane says, “We view potential for upside in…

This story appeared on benzinga.com, 2025-10-16 18:17:37.
The Entire Business World on a Single Page. Free to Use →